{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:51:33Z","timestamp":1791150693453,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1124\/mol.105.020776","type":"journal-article","created":{"date-parts":[[2006,2,24]],"date-time":"2006-02-24T20:34:21Z","timestamp":1140813261000},"page":"1624-1632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":211,"title":["Cytosolic Entry of Bisphosphonate Drugs Requires Acidification of Vesicles after Fluid-Phase Endocytosis"],"prefix":"10.1016","volume":"69","author":[{"given":"Keith","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fraser P.","family":"Coxon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie C.","family":"Crockett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.105.020776_bib1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0378-4347(97)00490-8","article-title":"Identification of adenine nucleotide-containing metabolites of bisphosphonate drugs using ion-pair liquid chromatography-electrospray mass spectrometry","volume":"704","author":"Auriola","year":"1997","journal-title":"J Chromatogr B"},{"key":"10.1124\/mol.105.020776_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/8756-3282(94)00035-X","article-title":"Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia models","volume":"16","author":"Azuma","year":"1995","journal-title":"Bone"},{"key":"10.1124\/mol.105.020776_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0026-895X(24)26392-6","article-title":"Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs","volume":"56","author":"Benford","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.105.020776_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/abbi.1999.1502","article-title":"Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase","volume":"373","author":"Bergstrom","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/mol.105.020776_bib5","doi-asserted-by":"crossref","first-page":"7972","DOI":"10.1073\/pnas.85.21.7972","article-title":"Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells and plant cells","volume":"85","author":"Bowman","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.105.020776_bib6","first-page":"89","article-title":"Isolation and purification of rabbit osteoclasts","volume":"80","author":"Coxon","year":"2003","journal-title":"Methods Mol Med"},{"key":"10.1124\/mol.105.020776_bib7","doi-asserted-by":"crossref","first-page":"48213","DOI":"10.1074\/jbc.M106473200","article-title":"Identification of a novel phosphonocarboxylate inhibitor of Rab geranylgeranyl transferase that specifically prevents Rab prenylation in osteoclasts and macrophages","volume":"276","author":"Coxon","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.105.020776_bib8","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1359\/jbmr.2000.15.8.1467","article-title":"Protein geranylgeranylation is required for osteoclast formation, function and survival: inhibition by bisphosphonates and GGTI-298","volume":"15","author":"Coxon","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1124\/mol.105.020776_bib9","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1359\/jbmr.1998.13.11.1730","article-title":"A new method to isolate large numbers of rabbit osteoclasts and osteoclast-like cells: application to the characterization of serum response element binding proteins during osteoclast differentiation","volume":"13","author":"David","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1124\/mol.105.020776_bib10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/283162a0","article-title":"Transglutaminase is essential in receptor-mediated endocytosis of alpha 2-macroglobulin and polypeptide hormones","volume":"283","author":"Davies","year":"1980","journal-title":"Nature (Lond)"},{"key":"10.1124\/mol.105.020776_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0022-3565(24)38786-5","article-title":"Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates","volume":"296","author":"Dunford","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.105.020776_bib12","first-page":"233","article-title":"Mechanisms of action of etidronate and other bisphosphonates","volume":"9","author":"Ebetino","year":"1998","journal-title":"Rev Contemp Pharmacother"},{"key":"10.1124\/mol.105.020776_bib13","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/1529-0131(200109)44:9<2201::AID-ART374>3.0.CO;2-E","article-title":"The molecular mechanism of action of the anti-resorptive and anti-inflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis","volume":"44","author":"Frith","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1124\/mol.105.020776_bib14","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1359\/jbmr.1997.12.9.1358","article-title":"Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5\u2032-(beta,gamma-dichloromethylene) triphosphate, by mammalian cells in vitro","volume":"12","author":"Frith","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1124\/mol.105.020776_bib15","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1359\/jbmr.2003.18.2.204","article-title":"Antagonistic effects of different classes of bisphosphonates in osteoclasts and macrophages in vitro","volume":"18","author":"Frith","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1124\/mol.105.020776_bib16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1172\/JCI200422087","article-title":"An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis","volume":"114","author":"Giraudo","year":"2004","journal-title":"J Clin Investig"},{"key":"10.1124\/mol.105.020776_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1634\/theoncologist.9-90004-3","article-title":"Bisphosphonates: preclinical review","volume":"9","author":"Green","year":"2004","journal-title":"Oncologist"},{"key":"10.1124\/mol.105.020776_bib18","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0021-9258(19)86019-2","article-title":"Dansylcadaverine inhibits internalization of 125I-epidermal growth factor in BALB 3T3 cells","volume":"255","author":"Haigler","year":"1980","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.105.020776_bib19","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/0014-4827(88)90316-3","article-title":"Effect of monensin on receptor recycling during continuous endocytosis of asialoorosomucoid","volume":"174","author":"Kaiser","year":"1988","journal-title":"Exp Cell Res"},{"key":"10.1124\/mol.105.020776_bib20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/8756-3282(95)00445-9","article-title":"Bisphosphonates: a review of their pharmacokinetic properties","volume":"18","author":"Lin","year":"1996","journal-title":"Bone"},{"key":"10.1124\/mol.105.020776_bib21","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1359\/jbmr.1998.13.11.1668","article-title":"Heterocycle-containing bisphosphonates cause apoptosis and inhibit bone resorption by preventing protein prenylation: evidence from structureactivity relationships in J774 macrophages","volume":"13","author":"Luckman","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1124\/mol.105.020776_bib22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.1998.13.4.581","article-title":"Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras","volume":"13","author":"Luckman","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1124\/mol.105.020776_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/8756-3282(96)00182-2","article-title":"Comparison of the distribution of 3H-alendronate and 3H-etidronate in rat and mouse bones","volume":"19","author":"Masarachia","year":"1996","journal-title":"Bone"},{"key":"10.1124\/mol.105.020776_bib24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0277-5387(01)00996-2","article-title":"Interations of zinc(II), magnesium(II) and calcium(II) with aminomethane-1,1-disphosphonic acids in aqueous solutions","volume":"21","author":"Matczak-Jon","year":"2002","journal-title":"Polyhedron"},{"key":"10.1124\/mol.105.020776_bib25","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1016\/j.ccr.2005.06.001","article-title":"Supramolecular chemistry and complexation abilities of diphosphonic acids","volume":"249","author":"Matczak-Jon","year":"2005","journal-title":"Coord Chem Rev"},{"key":"10.1124\/mol.105.020776_bib26","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1083\/jcb.127.5.1245","article-title":"An oligomeric protein is imported into peroxisomes in vivo","volume":"127","author":"McNew","year":"1994","journal-title":"J Cell Biol"},{"key":"10.1124\/mol.105.020776_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0968-0004(96)80181-2","article-title":"The targeting and assembly of peroxisomal proteins: some old rules do not apply","volume":"21","author":"McNew","year":"1996","journal-title":"Trends Biochem Sci"},{"key":"10.1124\/mol.105.020776_bib28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/10611869409015910","article-title":"Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound and free bisphosphonates in vitro","volume":"2","author":"M\u00f6nkk\u00f6nen","year":"1994","journal-title":"J Drug Target"},{"key":"10.1124\/mol.105.020776_bib29","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0022-2275(20)32353-1","article-title":"Identification of peroxisomal targeting signals in cholesterol biosynthetic enzymes. AA-CoA thiolase, HMG-CoA synthase, MPPD and FPP synthase","volume":"41","author":"Olivier","year":"2000","journal-title":"J Lipid Res"},{"key":"10.1124\/mol.105.020776_bib30","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.2174\/1381612033453640","article-title":"New insights into the molecular mechanisms of action of bisphosphonates","volume":"9","author":"Rogers","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.1124\/mol.105.020776_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S8756-3282(99)00116-7","article-title":"Bisphosphonates: from the laboratory to the clinic and back again","volume":"25","author":"Russell","year":"1999","journal-title":"Bone"},{"key":"10.1124\/mol.105.020776_bib32","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1172\/JCI115539","article-title":"Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure","volume":"88","author":"Sato","year":"1991","journal-title":"J Clin Investig"},{"key":"10.1124\/mol.105.020776_bib33","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1073\/pnas.79.7.2291","article-title":"Amantadine and dansylcadaverine inhibit vesicular stomatitis virus uptake and receptor-mediated endocytosis of alpha 2-macroglobulin","volume":"79","author":"Schlegel","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.105.020776_bib34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0006-291X(90)91709-2","article-title":"Inhibition of osteoclast proton transport by bafilomycin A1 abolishes bone resorption","volume":"168","author":"Sundquist","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/mol.105.020776_bib35","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S8756-3282(03)00024-3","article-title":"Involvement of vacuolar H+-ATPase in incorporation of risedronate into osteoclasts","volume":"32","author":"Takami","year":"2003","journal-title":"Bone"},{"key":"10.1124\/mol.105.020776_bib36","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1083\/jcb.111.3.1305","article-title":"Evidence for the presence of a proton pump of the vacuolar H+-ATPase type in the ruffled borders of osteoclasts","volume":"111","author":"Vaananen","year":"1990","journal-title":"J Cell Biol"},{"key":"10.1124\/mol.105.020776_bib37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/bbrc.1999.1499","article-title":"Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates","volume":"264","author":"van Beek","year":"1999","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24068299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24068299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.105.020776","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T04:07:12Z","timestamp":1740024432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24068299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0026895X24068299"],"URL":"https:\/\/doi.org\/10.1124\/mol.105.020776","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytosolic Entry of Bisphosphonate Drugs Requires Acidification of Vesicles after Fluid-Phase Endocytosis","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.105.020776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}